Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fran deGrazio

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Pharmaceutical Sciences|April 10, 2020
Injectable Combination Product Development: Facilitating Risk-Based Assessments for Efficiency and Patient Centric OutcomesFran DeGrazio, Diane Paskiet
PDA Journal of Pharmaceutical Science and Technology|January 18, 2026
Overcoming device component-related challenges and risks in prefilled syringe developmentBettine Boltres, Fran deGrazio, Susan Neadle
PDA Journal of Pharmaceutical Science and Technology|June 16, 2025
Economic Advantages of Original Container Closure Systems in Combination Product Development: Scenarios with Expert Validation and Industry-Quantified Cost-Time SavingsMehul Desai, Daniel Waites, William Rich, et al.
PDA Journal of Pharmaceutical Science and Technology|September 21, 2018
Achieving "Zero" Defects for Visible Particles in InjectablesJennifer Johns, Paolo Golfetto, Tia Bush, et al.
Pharmaceutical Research|January 10, 2008
Best practices for extractables and leachables in orally inhaled and nasal drug products: an overview of the PQRI recommendationsDaniel L Norwood, Diane Paskiet, Michael Ruberto, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Pharmaceutical Sciences|April 10, 2020
Injectable Combination Product Development: Facilitating Risk-Based Assessments for Efficiency and Patient Centric OutcomesFran DeGrazio, Diane Paskiet
PDA Journal of Pharmaceutical Science and Technology|January 18, 2026
Overcoming device component-related challenges and risks in prefilled syringe developmentBettine Boltres, Fran deGrazio, Susan Neadle
PDA Journal of Pharmaceutical Science and Technology|June 16, 2025
Economic Advantages of Original Container Closure Systems in Combination Product Development: Scenarios with Expert Validation and Industry-Quantified Cost-Time SavingsMehul Desai, Daniel Waites, William Rich, et al.
PDA Journal of Pharmaceutical Science and Technology|September 21, 2018
Achieving "Zero" Defects for Visible Particles in InjectablesJennifer Johns, Paolo Golfetto, Tia Bush, et al.
Pharmaceutical Research|January 10, 2008
Best practices for extractables and leachables in orally inhaled and nasal drug products: an overview of the PQRI recommendationsDaniel L Norwood, Diane Paskiet, Michael Ruberto, et al.
Pageof 1